Invitrogen™ Human IFN-gamma (ELISA Standard) Recombinant Protein, eBioscience™

Recombinant Protein

Supplier:  Invitrogen™ 29831965

Catalog No. 50-112-3493

Description

IFN gamma (Interferon gamma, Type II interferon) is a macrophage activation factor, and immune interferon that is produced primarily by T-lymphocytes and natural killer cells in response to antigens, mitogens, Staphylococcus enterotoxin B, phytohemaglutanin and other cytokines. IFN gamma is a dimeric protein consisting of two 146 amino acid subunits. IFN gamma is a glycoprotein that exists, functionally, as a homodimer of approximately 45 kDa. On SDS-PAGE, IFN gamma appears as a combination of 25, 20 and minor 15.5 kDa bands as a result of differential glycosylation. The biological activity of the IFN gamma homodimer is highly species specific. Human IFN gamma does not show cross-reactivity with mouse. IFN gamma function includes the following: antiviral activity, tumor antiproliferative activity, induction of class I and II MHC, macrophage activation, and enhanced immunoglobulin secretion by B lymphocytes. IFN gamma is involved in cytokine regulation and also acts synergistically with other cytokines. Activation of IFN gamma takes place through binding of IFN gamma receptor I and II, and activating the JAK-STAT pathway. IFN gamma does not show any homology with IFN alpha or IFN beta but human IFN gamma shows about 40% sequence homology with mouse IFN gamma. IFN gamma is upregulated by IL2, FGF basic, EGF and downregulated by vitamin D3 or DMN. IFN gamma gene mutations are associated with aplastic anemia. Description: Human IFN gamma is an ∽20 kDa factor produced by activated T, B and NK cells and is an anti-viral and anti-parasitic cytokine. IFN gamma in synergy with other cytokines, such as TNF alpha, inhibits proliferation of normal and transformed cells. Immunomodulatory effects of IFN gamma are exerted on a wide range of cell types expressing the high affinity receptors for IFN-gamma. Glycosylation of IFN gamma does not affect its biological activity. Applications Reported: Recombinant Human IFN gamma ELISA Standard, Lyoph has been reported for use iin the Human IFN gamma ELISA Ready Set Go! (cat 88-7316). Applications Tested: The intended use of the Human IFN gamma RSG ELISA Lyophilized Standard is as a standard for Human IFN gamma ELISA Ready-SET-Go!® (cat. 88-7316). Typically the standard is run in a series of 7 doubling dilutions from the ′top′ standard. Please refer to the Certificate of Analysis included with each ELISA set for instructions on the proper reconstitution and dilution of the lyophilized standard. Note: These are single-use vials. Use one time within 4 hours of reconstitution and discard. Reconstitute and dilute as suggested in the Certificate of Analysis or recovery may not be accurate. Source: E. coli expressed amino acids Gln24-Gln166 of mature human IFN gamma accession &Num; NM_000619.

Specifications

• Accession Number: P01579
• Format: Lyophilized
• Gene ID (Entrez): 3458
• Purity: Affinity chromatography
• Source: E. Coli
• Regulatory Status: RUO
• Gene Symbol: IFNG
• Conjugate: Unlabeled
• Host Species: E. coli
• Protein Subtype: Recombinant

• For Use With (Application): Control, ELISA
• Formulation: protein with no preservative
• Name: Human IFN gamma ELISA Standard
• Quantity: 4pack
• Storage Requirements: 4°C
• Common Name: Human IFN gamma ELISA Standard
• Specific Reactivity: Human
• Cross Reactivity: Hu
• Recombinant: Recombinant
• Validated Application: Control, ELISA

Safety and Handling

ShelfLife : 12 Months